Creotech Instruments SA

As of March 31, 2026, Creotech Instruments SA carries a market capitalization of 1.61B, placing it among publicly traded companies globally. Its enterprise value stands at 1.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Creotech Instruments SA's next confirmed earnings release is scheduled for December 2, 2026.

As of March 31, 2026, Creotech Instruments SA has 2.85M shares outstanding.

As of March 31, 2026, Creotech Instruments SA trades at a trailing price-to-earnings ratio of 301.61. The price-to-sales ratio is 11.55, and the price-to-book ratio stands at 11.44.

As of March 31, 2026, Creotech Instruments SA trades at an EV/EBITDA multiple of 55.73 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 11.25 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 119.40 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Creotech Instruments SA trades at an EV/FCF ratio of 837.36, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 1.56B versus a market cap of 1.61B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Creotech Instruments SA maintains a current ratio of 1.46, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 14.96, indicating elevated leverage, while an interest coverage ratio of 13.71 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Creotech Instruments SA posted a return on equity (ROE) of 3.71, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.16 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.90, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 4.18, useful for judging operating efficiency across full business cycles. The company generates approximately 536,368.22 in revenue per employee across its workforce of 258.00, a quick read on workforce productivity versus industry peers. Inventory turnover of -0.08 indicates how many times Creotech Instruments SA sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Creotech Instruments SA recorded 2.90M in income tax expense. That works out to an effective tax rate of 22.30, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 13.00M, leaving 5.30M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Creotech Instruments SA's stock has gained approximately 117.85% over the past 52 weeks. The 50-day moving average sits at 771.78, while the 200-day moving average is 716.34.

Over the twelve months ended March 31, 2026, Creotech Instruments SA generated 138.38M in revenue and converted that into 5.30M in net income, yielding earnings per share of 3.57. EBITDA reached 27.94M, while operating income came in at 13.04M.

As of March 31, 2026, Creotech Instruments SA holds 74.18M in cash and equivalents against 21.06M in total debt, resulting in a net debt position of -74.18M. Total book value stands at 140.73M, with working capital of 54.34M providing operational flexibility.

Creotech Instruments SA produced 276,000.00 in operating cash flow over the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Creotech Instruments SA posted a gross margin of 100.79, reflecting its pricing power and cost economics. The operating margin of 9.42 and net profit margin of 3.83 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 0.02, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.33, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Creotech Instruments SA shareholders.

As of March 31, 2026, Creotech Instruments SA has an Altman Z-Score of 6.74, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.